NCT03304080 2025-07-18Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastIcahn School of Medicine at Mount SinaiPhase 1/2 Active not recruiting44 enrolled
NCT06805812 2025-02-03PALMARES-2Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruiting3,500 enrolled